The US FDA just approved its 1st, 2 drug, 1-a-day, pill to fight HIV. This would limit having to deal with the dosages, costs, & side effects of 3+ meds daily to treat the virus. Juluca has show efficacy to do so with just 2 previously proven medications. GSK's Dolutegravir, via ViiV Healthcare is the 1st. Also known as Tivicay. The 2nd part is Janssen's Rilpivirine marketed as Edurant.
This article goes more into the details of the matter. Developing approaches that can lessen the number of drugs involved with a given regimen can hopefully lower costs & adverse effects of medications. The day of the mass cocktail regimen may very well be numbered. That's a good thing.
Cya...
No comments:
Post a Comment